Business Description
Bliss GVS Pharma Ltd
NAICS : 325412
ISIN : INE416D01022
Compare
Compare
Traded in other countries / regions
BLISSGVS.India IPO Date
2010-07-26Description
Bliss GVS Pharma Ltd is an India-based company engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. Geographically, it derives a majority of revenue from Outside India. Some of its brands include Lonart, P-Alaxin, Funbact, and Lofnac, and others. It offers pharma products including tablets, suspensions, suppositories, and injections. The majority of its revenue is derived from Exports.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 2.28 | |||||
| Equity-to-Asset | 0.8 | |||||
| Debt-to-Equity | 0.1 | |||||
| Debt-to-EBITDA | 0.67 | |||||
| Interest Coverage | 17.98 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 4.8 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.4 | |||||
| 3-Year EBITDA Growth Rate | 5.4 | |||||
| 3-Year EPS without NRI Growth Rate | 11 | |||||
| 3-Year FCF Growth Rate | 31 | |||||
| 3-Year Book Growth Rate | 5.6 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 17.47 | |||||
| 9-Day RSI | 29.25 | |||||
| 14-Day RSI | 36.31 | |||||
| 6-1 Month Momentum % | -20.87 | |||||
| 12-1 Month Momentum % | 58.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.08 | |||||
| Quick Ratio | 4.34 | |||||
| Cash Ratio | 1.42 | |||||
| Days Inventory | 110.4 | |||||
| Days Sales Outstanding | 184.43 | |||||
| Days Payable | 74.84 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.47 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| Forward Dividend Yield % | 0.47 | |||||
| 5-Year Yield-on-Cost % | 0.21 | |||||
| 3-Year Average Share Buyback Ratio | -0.5 | |||||
| Shareholder Yield % | 0.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 50.39 | |||||
| Operating Margin % | 16.13 | |||||
| Net Margin % | 9.31 | |||||
| FCF Margin % | 16.11 | |||||
| ROE % | 7.73 | |||||
| ROA % | 6.03 | |||||
| ROIC % | 9.22 | |||||
| ROC (Joel Greenblatt) % | 14.67 | |||||
| ROCE % | 12.21 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14.93 | |||||
| PE Ratio without NRI | 14.93 | |||||
| Shiller PE Ratio | 11.09 | |||||
| Price-to-Owner-Earnings | 16.53 | |||||
| PS Ratio | 1.41 | |||||
| PB Ratio | 1.16 | |||||
| Price-to-Tangible-Book | 1.17 | |||||
| Price-to-Free-Cash-Flow | 9.14 | |||||
| Price-to-Operating-Cash-Flow | 7.44 | |||||
| EV-to-EBIT | 8.02 | |||||
| EV-to-EBITDA | 6.61 | |||||
| EV-to-Revenue | 1.29 | |||||
| EV-to-FCF | 8 | |||||
| Price-to-Projected-FCF | 1.14 | |||||
| Price-to-Graham-Number | 0.79 | |||||
| Price-to-Net-Current-Asset-Value | 1.98 | |||||
| Earnings Yield (Greenblatt) % | 12.47 | |||||
| FCF Yield % | 11.09 | |||||
| Forward Rate of Return (Yacktman) % | -4.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bliss GVS Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 7,702.449 | ||
| EPS (TTM) (₹) | 7.16 | ||
| Beta | 1.23 | ||
| Volatility % | 77.94 | ||
| 14-Day RSI | 36.31 | ||
| 14-Day ATR (₹) | 4.160087 | ||
| 20-Day SMA (₹) | 114.0075 | ||
| 12-1 Month Momentum % | 58.74 | ||
| 52-Week Range (₹) | 72 - 149.6 | ||
| Shares Outstanding (Mil) | 104.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bliss GVS Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bliss GVS Pharma Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Bliss GVS Pharma Ltd Frequently Asked Questions
What is Bliss GVS Pharma Ltd(NSE:BLISSGVS)'s stock price today?
The current price of NSE:BLISSGVS is ₹106.65. The 52 week high of NSE:BLISSGVS is ₹149.60 and 52 week low is ₹72.00.
When is next earnings date of Bliss GVS Pharma Ltd(NSE:BLISSGVS)?
The next earnings date of Bliss GVS Pharma Ltd(NSE:BLISSGVS) is .
Does Bliss GVS Pharma Ltd(NSE:BLISSGVS) pay dividends? If so, how much?
The Dividend Yield %  of Bliss GVS Pharma Ltd(NSE:BLISSGVS) is 0.47% (As of Today), Highest Dividend Payout Ratio of Bliss GVS Pharma Ltd(NSE:BLISSGVS) was 0.21. The lowest was 0.06. And the median was 0.08. The  Forward Dividend Yield % of Bliss GVS Pharma Ltd(NSE:BLISSGVS) is 0.47%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers